A Phase 1, Single Ascending Dose Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease.

Trial Profile

A Phase 1, Single Ascending Dose Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs MEDI 2338 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 11 May 2012 Actual patient number added 31 according to ClinicalTrials.gov.
    • 11 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Aug 2011 Planned End Date changed from 1 Feb 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top